4-Aminopyridine

Results: 41



#Item
1Microsoft WordFampridine FAMPYRA Biogen IdecPSD FINAL.doc

Microsoft WordFampridine FAMPYRA Biogen IdecPSD FINAL.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:22
2Clinical Commissioning Policy Statement: Fampridine for Multiple Sclerosis (MS) April 2013

Clinical Commissioning Policy Statement: Fampridine for Multiple Sclerosis (MS) April 2013

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2014-08-12 08:05:39
3ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  This medicinal product is subject to additional monitoring. This will allow quick identification of

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2014-12-09 11:55:19
4Acknowledgement  We acknowledge and pay respect to the traditional custodians past and present on whose lands we meet today. We acknowledge the deep feelings of attachment

Acknowledgement We acknowledge and pay respect to the traditional custodians past and present on whose lands we meet today. We acknowledge the deep feelings of attachment

Add to Reading List

Source URL: www.mssociety.org.au

Language: English - Date: 2015-02-08 17:33:15
5HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA® (dalfampridine) Extended Releas

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA® (dalfampridine) Extended Releas

Add to Reading List

Source URL: ampyra.com

Language: English - Date: 2014-04-30 10:43:13
6

PDF Document

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2013-08-13 12:09:51
7Microsoft Word - CSRO-FACTSHEET

Microsoft Word - CSRO-FACTSHEET

Add to Reading List

Source URL: www.csro.com

Language: English - Date: 2012-04-11 17:41:36
8Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function Philippe Martel, Damiana Leo, Stephanie Fulton, Maxime Be´rard, Louis-Eric Trudeau* Department of Pharmacology, Faculty

Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function Philippe Martel, Damiana Leo, Stephanie Fulton, Maxime Be´rard, Louis-Eric Trudeau* Department of Pharmacology, Faculty

Add to Reading List

Source URL: www.mapageweb.umontreal.ca

Language: English - Date: 2011-05-27 23:33:04
9Today’s date Plan name Plan address Re: (Claimant’s name, claim #) Dear Sir or Ms.: This is an appeal for reconsideration of (____your denial of coverage/pre-authorization,

Today’s date Plan name Plan address Re: (Claimant’s name, claim #) Dear Sir or Ms.: This is an appeal for reconsideration of (____your denial of coverage/pre-authorization,

Add to Reading List

Source URL: www.nationalmssociety.org

Language: English - Date: 2014-09-11 11:12:38
10US EPA - Reregistration Eligibility Decision for 4-aminopyridine

US EPA - Reregistration Eligibility Decision for 4-aminopyridine

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2007-12-04 13:56:49